Research and Development

Showing 15 posts of 9573 posts found.

Wellcome Trust announces £250m fund for high risk ideas

July 11, 2018 Research and Development 250 million, Wellcome, britain, leap fund, pharma

The London-based biomedical research charity the Wellcome Trust, Britain’s wealthiest foundation, has announced the launch of a new £250 million …
shutterstock_254160583

Trump forces Pfizer to back down and delay price hikes until 2019

July 11, 2018 Research and Development, Sales and Marketing Alex Azar, Donald Trump, Ian Read, Pfizer, President trump, Trump, druig pricing, pharma

Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …
mario_saltarelli_cropped

Syntimmune appoints Pfizer, AbbVie veteran as new CMO

July 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, John Hopkins University, Pfizer, Syntimmune

The Boston-based clinical biotechnology company Syntimmune has appointed Dr Mario Saltarelli as its Chief Medical Officer. Dr Saltarelli will take …

NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears

July 10, 2018 Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma

NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 9, 2018 Research and Development, Sales and Marketing

The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …
shutterstock_212035546

Extended use of breast cancer drug tamoxifen linked to increased endometrial cancer risk

July 9, 2018 Research and Development, Sales and Marketing Cancer, breast cancer, endometrial cancer, pharma, tamoxifen

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …

Insider Interview: Biosimilars to balance the books

July 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …
michel_porro-getty_images

Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%

July 6, 2018 Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …
shutterstock_gonnorrhea

Ipsen reveals positive Phase 3 data of Cabometyx in liver cancer

July 5, 2018 Research and Development Cabometyx, Cancer, ipsen, liver cancer, pharma

French pharmaceutical company Ipsen has announced that The New England Journal of Medicine has published the results of a Phase …
640px-hiv-budding-color

Abivax drug lowers HIV DNA in blood and tissue, but has the opposite effect for some

July 4, 2018 Research and Development Abivax, HIV, pharma

Biotechnology firm Abivax has lifted the curtain on new Phase 2a data for its HIV therapy ABX464, showing that the …
Medicinal cannabis in a laboratory

Review signals step towards legalisation of medicinal cannabis in UK

July 4, 2018 Research and Development England, cannabis, pharma, review, thc

England’s Chief Medical Officer Dame Sally Davies has concluded that there is “conclusive evidence” that cannabis is medically beneficial for …
money-pills-pharma-file

GSK Director indicted in Massachusetts opioid lawsuit

July 4, 2018 Research and Development, Sales and Marketing

The state of Massachusetts has taken action to sue a board member at GlaxoSmithKline for her alleged role in fuelling …
800px-lab_mouse_mg_3154

Promising new drug slows Parkinson’s progression in mice

July 4, 2018 Research and Development John Hopkins University, Parkinson's diabetes, pharma

Researchers from John Hopkins University have developed an experimental drug that slows the progression of Parkinson’s disease in mice. The …
The Gateway to Local Adoption Series

Latest content